STOCK TITAN

Concentrix SEC Filings

CNXC NASDAQ

Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Concentrix Corporation filings document the company’s results, governance, financing arrangements and capital structure as a public technology and services issuer. Form 8-K reports include quarterly and annual operating results, dividend and share repurchase information, material agreements, debt offerings, note redemptions and amendments to its accounts receivable securitization facility through Concentrix Receivables, Inc.

Proxy and annual meeting filings cover director elections, auditor ratification, executive compensation votes and amendments to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan. Other governance disclosures address board composition and investor-rights provisions associated with the company’s Webhelp acquisition history.

Rhea-AI Summary

Concentrix Corp director LaVerne H. Council received an equity award of 7,701 shares of Common Stock in the form of restricted stock units. These RSUs were granted at no cash exercise price and increase her direct holdings to 17,704 shares following the award. The units vest in full on the earlier of the one-year anniversary of the grant date or the company’s 2027 Annual Meeting of Stockholders, aligning director compensation with long-term shareholder interests.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cheng Chih-Kai reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Cheng Chih-Kai received a grant of 7,701 shares of Common Stock as restricted stock units. These RSUs were awarded at no cash purchase price under the company’s 2020 Stock Incentive Plan and represent his entire reported direct holding after the transaction.

The restricted stock units will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix Corp’s 2027 Annual Meeting of Stockholders. This filing reflects a compensation-related equity award rather than an open-market share purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

OGUT BILGE reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Bilge Ogut received 7,701 shares of common stock as a restricted stock unit award. The grant was made at no cash cost to the director and represents equity-based compensation rather than an open-market purchase or sale.

According to the terms, these restricted stock units vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. After this award, Ogut holds 7,701 shares directly, aligning personal ownership with shareholder interests through time-based vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Deason Jennifer reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Jennifer Deason received an equity award rather than buying shares on the market. She was granted 7,701 shares of common stock in the form of restricted stock units at no cash purchase price, increasing her direct holdings to 17,704 shares.

The restricted stock units were awarded under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders. This is a compensation-related grant, not an open-market transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Hayley Kathryn reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Hayley Kathryn received an equity award of 7,701 shares of Common Stock as restricted stock units under the 2020 Stock Incentive Plan. The units were granted at no cash cost and will vest in full on the earlier of the one-year anniversary of grant or the company’s 2027 Annual Meeting of Stockholders.

After this award, Kathryn directly holds 17,712.1206 shares. She also has an indirect holding of 3,034.2930 shares held by a trust, giving her both direct and trust-based exposure to Concentrix stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Marinello Kathryn V reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Kathryn V. Marinello received an equity grant of 7,701 shares of common stock as restricted stock units. The award was made at no cash price under the 2020 Stock Incentive Plan and vests in full on the earlier of the one-year anniversary of the grant date or the issuer's 2027 Annual Meeting of Stockholders. Following this grant, she directly holds 17,704 shares of Concentrix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

POLK DENNIS reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Dennis Polk received an equity award of 7,701 shares of Common Stock in the form of restricted stock units. The grant was made at no cash cost per share and increased his direct holdings to 28,924 shares. These restricted stock units, awarded under the 2020 Stock Incentive Plan, vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

VEZINA ANN F reported acquisition or exercise transactions in this Form 4 filing.

Concentrix Corp director Ann F. Vezina received a grant of 7,701 shares of Common Stock in the form of restricted stock units. The award was made at no cash price and increases her direct holdings to 19,648 shares.

The restricted stock units were granted under the 2020 Stock Incentive Plan and will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corporation reported results of its 2026 annual stockholder meeting. Stockholders approved an amendment to the Concentrix Corporation Amended and Restated 2020 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 3,700,000 shares.

They also elected nine directors for terms expiring at the 2027 annual meeting and ratified Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026. In an advisory vote, stockholders approved the compensation of the company’s named executive officers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Concentrix Corp director Bilge Ogut has filed an initial Form 3 insider ownership report. This filing establishes Ogut’s status as a reporting insider of the company. The data show no share purchases, sales, option exercises, gifts, or other transactions in this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Concentrix (CNXC) SEC filings are available on StockTitan?

StockTitan tracks 79 SEC filings for Concentrix (CNXC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Concentrix (CNXC)?

The most recent SEC filing for Concentrix (CNXC) was filed on March 27, 2026.